IL106375A0 - Megakarocyte differentiation factor,dna coding therefor,processes for the preparation thereof,and a pharmaceutical composition containing the same - Google Patents

Megakarocyte differentiation factor,dna coding therefor,processes for the preparation thereof,and a pharmaceutical composition containing the same

Info

Publication number
IL106375A0
IL106375A0 IL106375A IL10637593A IL106375A0 IL 106375 A0 IL106375 A0 IL 106375A0 IL 106375 A IL106375 A IL 106375A IL 10637593 A IL10637593 A IL 10637593A IL 106375 A0 IL106375 A0 IL 106375A0
Authority
IL
Israel
Prior art keywords
processes
preparation
pharmaceutical composition
composition containing
same
Prior art date
Application number
IL106375A
Other languages
English (en)
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of IL106375A0 publication Critical patent/IL106375A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
IL106375A 1992-07-17 1993-07-16 Megakarocyte differentiation factor,dna coding therefor,processes for the preparation thereof,and a pharmaceutical composition containing the same IL106375A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21230592 1992-07-17
JP6733993 1993-03-04

Publications (1)

Publication Number Publication Date
IL106375A0 true IL106375A0 (en) 1993-11-15

Family

ID=26408534

Family Applications (1)

Application Number Title Priority Date Filing Date
IL106375A IL106375A0 (en) 1992-07-17 1993-07-16 Megakarocyte differentiation factor,dna coding therefor,processes for the preparation thereof,and a pharmaceutical composition containing the same

Country Status (11)

Country Link
US (5) US5831030A (ko)
EP (1) EP0583884B1 (ko)
JP (1) JP3521936B2 (ko)
KR (2) KR940005799A (ko)
AU (2) AU4190893A (ko)
CA (1) CA2100690C (ko)
DE (1) DE69314574T2 (ko)
DK (1) DK0583884T3 (ko)
ES (1) ES2108228T3 (ko)
HU (1) HU218411B (ko)
IL (1) IL106375A0 (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0775593A (ja) * 1993-09-08 1995-03-20 Suntory Ltd 蛋白質の製造方法
US8357513B1 (en) 1994-01-03 2013-01-22 Genentech, Inc. Nucleic acids encoding mpl ligand (thrombopoietin) and fragments thereof
US5795569A (en) * 1994-03-31 1998-08-18 Amgen Inc. Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation
RO115788B1 (ro) * 1994-03-31 2000-06-30 Amgen Inc. Polipeptidă mgdf, derivat de polipeptidă mgdf, polipeptidă mgdf mono-pegilată şi procedee de obţinere a acestora
TW434021B (en) * 1995-03-15 2001-05-16 Kirin Brewery Methods for preventing adsorption of thrombopoietin (TPO), and stable TPO-containing compositions
TW434020B (en) * 1995-03-15 2001-05-16 Kirin Brewery Methods for preventing adsorption of thrombopoietin (TPO), and stable top-containing compositions
TW497972B (en) * 1995-06-08 2002-08-11 Kirin Brewery Stable thrombopoietin (TPO)-containing lyophilized compositions
AU743025B2 (en) * 1997-03-12 2002-01-17 Applera Corporation DNA polymerases having improved labeled nucleotide incorporation properties
AU2763302A (en) * 1997-09-22 2002-05-16 Kurokawa, Kiyoshi Megsin protein
EP1018551A4 (en) * 1997-09-22 2003-07-23 Toshio Miyata MEGSINE PROTEIN
KR100606388B1 (ko) * 1999-03-19 2006-07-28 구로카와 기요시 멕신단백질의 검출방법 및 그 용도
US7056661B2 (en) * 1999-05-19 2006-06-06 Cornell Research Foundation, Inc. Method for sequencing nucleic acid molecules
WO2001024628A1 (fr) * 1999-10-06 2001-04-12 Kurokawa, Kiyoshi Modele animal pour nephrite proliferative a cellules mesangiales
WO2001048019A1 (fr) * 1999-12-28 2001-07-05 Kurokawa, Kiyoshi Methode permettant de diagnostiquer la nephrite proliferative a cellules mesangiales chez le rat
US20040253242A1 (en) * 2000-12-05 2004-12-16 Bowdish Katherine S. Rationally designed antibodies
US7396917B2 (en) * 2000-12-05 2008-07-08 Alexion Pharmaceuticals, Inc. Rationally designed antibodies
EP1642910B1 (en) * 2000-12-05 2012-02-08 Alexion Pharmaceuticals, Inc. Rationally designed antibodies
US20050042629A1 (en) 2002-09-13 2005-02-24 Applera Corporation Thermus scotoductus nucleic acid polymerases
WO2003048308A2 (en) 2001-11-30 2003-06-12 Applera Corporation Thermus brockianus nucleic acid polymerases
ATE471722T1 (de) * 2003-03-12 2010-07-15 Univ Arizona State Verfahren zur regulierung von angiogenese mit apelin-zusammensetzungen
US7879318B2 (en) 2006-01-23 2011-02-01 Mcw Research Foundation, Inc. Method of reducing the effects of ischemia by administration of a thrombopoietin receptor ligand

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894440A (en) * 1986-09-17 1990-01-16 Massachusetts Institute Of Technology Method of isolating megakaryocyte stimulatory factor
IL90719A0 (en) * 1988-06-28 1990-01-18 Yissum Res Dev Co Novel nuclei acids and polypeptides encoded thereby
US5032396A (en) * 1989-02-17 1991-07-16 Immunex Corporation IL-7 to stimulate platelet production

Also Published As

Publication number Publication date
AU7538796A (en) 1997-02-20
EP0583884A1 (en) 1994-02-23
DE69314574D1 (de) 1997-11-20
CA2100690C (en) 2007-04-17
KR940005799A (ko) 1994-03-22
DK0583884T3 (da) 1998-03-16
AU703648B2 (en) 1999-03-25
US5874253A (en) 1999-02-23
US5972886A (en) 1999-10-26
CA2100690A1 (en) 1994-01-18
HUT67124A (en) 1995-02-28
US5831030A (en) 1998-11-03
US20020164711A1 (en) 2002-11-07
EP0583884B1 (en) 1997-10-15
HU9302059D0 (en) 1993-11-29
HU218411B (hu) 2000-08-28
AU4190893A (en) 1994-01-20
DE69314574T2 (de) 1998-02-19
ES2108228T3 (es) 1997-12-16
JPH06313000A (ja) 1994-11-08
KR100397244B1 (ko) 2003-12-01
US20010026931A1 (en) 2001-10-04
JP3521936B2 (ja) 2004-04-26

Similar Documents

Publication Publication Date Title
IL106375A0 (en) Megakarocyte differentiation factor,dna coding therefor,processes for the preparation thereof,and a pharmaceutical composition containing the same
IL106600A (en) Peptides, pharmaceutical compositions containing the same and processes for the preparation thereof
EP0670716A4 (en) TASTE-MASKED PHARMACEUTICAL SUBSTANCES.
IL106326A0 (en) Peptides, their production and pharmaceutical compositions containing them
LTIP1467A (en) Tertiary hydroxyalkylxantines, process for the preparation thereof and pharmaceutical composition containing them
GB2220206B (en) Carboxamide compounds,processes for preparing the same and a pharmaceutical composition containing the same
GB9113219D0 (en) Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same
ZA89958B (en) Pharmaceutical compositions containing lactams,new substituted lactams and processes for the preparation thereof
AU2837089A (en) New indolylpiperidine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
IL108308A0 (en) Polypeptides, their production and pharmaceutical compositions containing them
GB2272375B (en) Pharmaceutical composition
EP0587047A3 (en) Gestagenes containing pharmaceutical composition
IL107358A0 (en) a-Phosphonosulfonate derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
IL78576A0 (en) 5-pyrimidinecarboxamide,processes for the preparation thereof and pharmaceutical compositions containing same
EP0543263A3 (en) Benziimidazoles, pharmaceuticals containing them and process for their preparation
ZA941088B (en) Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them
HU9503031D0 (en) Pharmaceutical composition containing von willerbrand factor
GB9310075D0 (en) New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IL107808A0 (en) Diarylalkane derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
ZA897228B (en) Pharmaceuticals containing 2,7-diamino-1,2,3,4-tetrahydronaphthalines,new compounds and manufacture
ZA9610002B (en) New compounds pharmaceutical preparations containing them and a process for the preparation thereof
IL106433A0 (en) Furylthiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
LTIP606A (en) Peptide compounds, method for the preparation and use thereof
ZA9364B (en) Pyridysulphonylure compound, processes for the preparation thereof, and pharmaceutical compositions containing it
GB9216102D0 (en) Pharmaceutical substances

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees